A-Z Supplier directory OTC Directory Room hire Contact us

| Members login Register

OTC medicines

OTC medicines

OTC medicines advertising workshop

This workshop gives you an overview of the self-regulatory system for OTC medicines advertising and how this applies to your campaigns.

Medical devices

Medical devices

Medical devices consumer code workshop

This workshop gives you an overview of the rules around advertising medical devices and provides practical advice on keeping your campaigns compliant.

Food supplements

Food supplements

Food supplements regulatory workshop

Find out what regulations apply to food supplements products and what this means for your brands.

News

News

Media statements

Read our latest media statements released in response to media issues affecting the consumer healthcare industry (members only).

Media statements

Policy

Policy

The economic value of the OTC healthcare sector

This report showcases the current and potential impact of OTC usage in the UK.

Membership

Membership

The economic value of the OTC healthcare sector

This report showcases the current and potential impact of OTC usage in the UK.

Training & events

Training & events

Membership

We are the only trade association representing the interests of manufacturers of branded OTC medicines, self-care medical devices and food supplements in the UK.

About PAGB

About PAGB

The economic value of the OTC healthcare sector

This report showcases the current and potential impact of OTC usage in the UK.

Back

Home / News / DHPC (direct to healthcare professional communication) letter regarding pholcodine

DHPC (direct to healthcare professional communication) letter regarding pholcodine

Pholcodine-containing medicinal products are no longer available on the UK market

Following a review by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator has taken the precautionary step to recall medicines containing pholcodine.

The DHPC (direct to healthcare professional communication) letter below has been sent to healthcare providers from PAGB on behalf of the Marketing Authorisation Holders of medicines containing pholcodine. All batches of the products listed in the Appendix I of the letter have been recalled.

Read the letter. If you have any queries about the products being recalled, please contact the relevant company via the details in the table.

Related news

View all

19 November 2025

Self-Care Week blog post from Mike Knowland

In the latest of our series of blog posts this Self-Care Week, Mike shares how OTC brands stand ready to support the Government’s commitments to implement a self-care offer across NHS digital platforms, sharing the recommendations that PAGB are championing to deliver this reform.

18 November 2025

Michelle Riddalls OBE talks reclassification and digital reform on HBW Over The Counter podcast

This week, HBW are landing two new podcast episodes for their Over The Counter series interviewing Michelle Riddalls OBE, CEO at PAGB. These focus on the key messages PAGB are sharing across their expert authored blog posts this Self-Care Week.

18 November 2025

Self-Care Week blog post from Michelle Riddalls OBE

To mark Self-Care Week, Michelle Riddalls OBE has authored a blog post on the important role that reclassification has to play in the Government’s agenda to move from sickness to prevention and reduce pressures on primary care. Through greater reclassification of over-the-counter products, we can improve access to self-care, reduce GP visits and empower patients, whilst delivering up to £1.4 billion in savings to NHS prescribing costs annually.

13 November 2025

PAGB hosts strategic meeting with MHRA and member companies

PAGB, the consumer healthcare association, hosted a pivotal meeting with Lawrence Tallon, Chief Executive Officer and Julian Beach, Interim Executive Director Healthcare Quality and Access at the Medicines and Healthcare products Regulatory Agency (MHRA), as the agency shapes its new five-year strategy.

19 November 2025

Self-Care Week blog post from Mike Knowland

In the latest of our series of blog posts this Self-Care Week, Mike shares how OTC brands stand ready to support the Government’s commitments to implement a self-care offer across NHS digital platforms, sharing the recommendations that PAGB are championing to deliver this reform.

18 November 2025

Michelle Riddalls OBE talks reclassification and digital reform on HBW Over The Counter podcast

This week, HBW are landing two new podcast episodes for their Over The Counter series interviewing Michelle Riddalls OBE, CEO at PAGB. These focus on the key messages PAGB are sharing across their expert authored blog posts this Self-Care Week.

18 November 2025

Self-Care Week blog post from Michelle Riddalls OBE

To mark Self-Care Week, Michelle Riddalls OBE has authored a blog post on the important role that reclassification has to play in the Government’s agenda to move from sickness to prevention and reduce pressures on primary care. Through greater reclassification of over-the-counter products, we can improve access to self-care, reduce GP visits and empower patients, whilst delivering up to £1.4 billion in savings to NHS prescribing costs annually.

13 November 2025

PAGB hosts strategic meeting with MHRA and member companies

PAGB, the consumer healthcare association, hosted a pivotal meeting with Lawrence Tallon, Chief Executive Officer and Julian Beach, Interim Executive Director Healthcare Quality and Access at the Medicines and Healthcare products Regulatory Agency (MHRA), as the agency shapes its new five-year strategy.

View all